Ware Olivia C

Ware Olivia C is listed in filings as Director at Arcellx, Inc.. This profile follows SEC Form 4 activity through Apr 28, 2026, including 8 public disclosures. Recent filings connect the profile to Arcellx, Inc. (ACLX), Contineum Therapeutics, Inc. Class A Common Stock (CTNM), and Revance Therapeutics, Inc. - Common Stock (RVNC). The current snapshot covers public activity from Feb 6, 2025 to Apr 28, 2026. Reported amounts are shown as $584.2K to $411.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.